John Sakys - 22 Mar 2023 Form 4 Insider Report for MESA LABORATORIES INC /CO/ (MLAB)

Role
CFO
Signature
John Sakys
Issuer symbol
MLAB
Transactions as of
22 Mar 2023
Net transactions value
-$296,650
Form type
4
Filing time
27 Mar 2023, 09:40:12 UTC
Previous filing
16 Mar 2023
Next filing
16 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MLAB Common Stock Options Exercise $306,650 +2,500 +26% $122.66 12,196 22 Mar 2023 Direct
transaction MLAB Common Stock Sale $429,050 -2,500 -20% $171.62 9,696 22 Mar 2023 Direct F3
transaction MLAB Common Stock Options Exercise $122,660 +1,000 +10% $122.66 10,696 24 Mar 2023 Direct
transaction MLAB Common Stock Sale $167,010 -1,000 -9.3% $167.01 9,696 24 Mar 2023 Direct F3
transaction MLAB Common Stock Options Exercise $58,487 +1,128 +12% $51.85 10,824 24 Mar 2023 Direct
transaction MLAB Common Stock Sale $188,387 -1,128 -10% $167.01 9,696 24 Mar 2023 Direct F3
holding MLAB Common Stock 100 22 Mar 2023 Custodian F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MLAB Non Qualified Stock Option Exercise of in-the-money or at-the-money derivative security $0 -2,500 -9.5% $0.000000 23,802 22 Mar 2023 Common Stock 2,500 $122.66 Direct F1
transaction MLAB Non Qualified Stock Option Exercise of in-the-money or at-the-money derivative security $0 -1,000 -4.2% $0.000000 22,802 24 Mar 2023 Common Stock 1,000 $122.66 Direct F1
transaction MLAB Non Qualified Stock Option Exercise of in-the-money or at-the-money derivative security $0 -1,128 -4.9% $0.000000 21,674 24 Mar 2023 Common Stock 1,128 $51.85 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/5 exercisable on each anniversary date of the 04/03/17 grant date
F2 1/4 exercisable on each anniversary date of the 04/01/2013 grant date
F3 Sale reported on the Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on June 14, 2022
F4 Consists of 100 shares held by children of which Mr. Sakys is custodian